Prominent molecular features of NEPC/small cell carcinoma include loss of RB1 and TP53, low or absent AR and AR pathway outputs, and induction of SOX2 and the epigenetic enzymes EZH2 and DNMT1. Here, EZH2 is linked to small cell carcinoma.